Using data collected from Fitbit smartwatches and fed to an AI model, a team was able to unearth links between genetic ...

Women with amnestic mild cognitive impairment and early Alzheimer’s disease had lower levels of acetyl-L-carnitine and its ...

Machine learning and artificial intelligence (AI) techniques and analysis of large datasets have helped University of ...

AX-158 has achieved clinical validation through its phase 2a trial for the treatment of patients with mild to moderate plaque ...

By studying biomarkers known to be involved in gastrointestinal cancers, researchers have developed a biomarker algorithm that, when combined with a noninvasive method to collect esophageal cells for ...

New University of Virginia School of Medicine research revealing the fingerprints of Sudden Infant Death Syndrome (SIDS) ...

“This study results offer valuable insight for identifying potential biomarkers in future proteomic studies and it is hoped this knowledge will eventually help improve treatments for patients with ...

Scientists mapped the serum proteome longitudinally to uncover biomarkers linked to healthy aging and cardiometabolic ...

Neurological biomarkers market size was valued at USD 9.5 billion in 2024 and is expected to grow at a compound annual growth rate (CAGR) of 10.9% between 2025 and 2034. The rising prevalence of ...

Ajay Goel, PhD, AGAF, discusses how the development and validation of novel non-invasive biomarkers can improve early detection and ultimately impact patient outcomes for patients.

Understanding and predicting individual responses to common stressors is essential for optimising performance in high-stress ...

Neurological biomarkers industry is projected to witness a CAGR of 10.9% during the period 2025-2034. This growth can be ...